|Articles|February 19, 2016

Make the Pain Stop: New Shared Platform Eases Investigators’ Burden

Author(s)DIA

Make the Pain Stop: New Shared Platform Eases Investigators’ Burden

TransCelerate BioPharma Inc. CEO Dr. Dalvir Gill shares results of their recent collaboration with the Society for Clinical Research Sites: The Shared Investigator Platform designed to reduce administrative burden by enabling investigative sites to interact with multiple clinical trial sponsors through a single point of access.

Read the article here.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

Make the Pain Stop: New Shared Platform Eases Investigators’ Burden

Newsletter

Related Content

Merck to Acquire Cidara for $9.2 Billion

Invictus Pharmacy Becomes First US Pharmacy to Accept Cryptocurrency for Prescriptions

Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML

Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval

How Are Executives Adapting Their Growth Strategies to the Current Environment?